TGTX: Tg Therapeutics Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
433 institutions reported holding $5.86B of Tg Therapeutics Inc on Form 13F (366 the quarter before). 102 opened a new position and 35 sold out. Shares held by institutions: +5%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 22,050,045 | $1.21B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7,963,266 | $437.50M |
| STATE STREET CORP | 7,786,471 | $427.79M |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,149,403 | $337.85M |
| GEODE CAPITAL MANAGEMENT, LLC | 3,642,216 | $200.14M |
| D. E. Shaw & Co., Inc. | 3,400,808 | $186.84M |
| Soleus Capital Management, L.P. | 2,927,895 | $160.86M |
| Clearbridge Investments, LLC | 2,650,192 | $145.60M |
| CONGRESS ASSET MANAGEMENT CO | 2,600,123 | $142.85M |
| TWO SIGMA INVESTMENTS, LP | 2,468,971 | $135.65M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.